Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.130
+0.060 (2.90%)
Jan 12, 2026, 4:00 PM EST - Market closed
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $207.93 million as of January 13, 2026. Its market cap has increased by 108.14% in one year.
Market Cap
207.93M
Enterprise Value
61.93M
1-Year Change
108.14%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $207.93M, a decrease of -68.00%. That is a compound annual growth rate of -10.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 207.90M | 3.90% |
| Dec 31, 2025 | 200.10M | 90.94% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |